Quanterix Corp QTRX

$2.83 -0.03 (-1.05%)

Valuation

Market cap
135,258,000
Revenue TTM
$138,900,000
Net income TTM
$-107,150,000
PE ratio
0.00
Forward PE
—
Profit margin
-77.14%
Debt to equity
0.00

Trading

Volume
148,474
Avg volume
711,120
Day's range
$2.79 – $2.90
Shares out
47,293,000
Stochastic %K
28%
Beta
1.02
Analysts
Hold
Price target
$3.17

Price

Company profile

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemi...

Show more

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
617 301 9400
Website
https://www.quanterix.com
Address
Building 1, 900 Middlesex Turnpike, Billerica, United States

Latest news

Stocktwits

BioGem Oct 20, 8:17 PM
$QTRX I am holding onto my short until the bloodbath expected after the Q3 report. We all know this will post big losses and cash burn. Other criticism as below. The market will hate it.
2 replies
SQUEAKSBANDIT Oct 19, 2:26 PM
$QTRX anyone cash out above 3.50?
0 replies
AC_TRADER Oct 11, 7:05 AM
$QTRX key levels mapped in seconds with @TrendSpider. https://share.trendspider.com/chart/QTRX/75943haej5
0 replies
Valueforall Oct 5, 7:24 PM
$QTRX some mudhaphukkas are buying the dips. This mudhaphucka is buying the rips !
0 replies
sogenerous Sep 22, 4:12 PM
$QTRX interesting setup here with insider buys on potential climax sell-off low - was trading below cash few days ago - thin trading but could be good for spec off 2-3s. Genomics/Bios doing well
0 replies
MingChoo Sep 16, 1:26 AM
$QTRX
0 replies
IOMASS Sep 15, 5:15 PM
$QTRX Big volume yesterday, guess a large seller got taken out - question is with today's trading reaction, did a key investor finally get involved done here?
1 replies
HiringLawyers Sep 11, 5:16 AM
$QTRX This was always an Alzheimers play. Gold standard diagnostic test. Without a therapy, no one needs diagnosis. Now it looks like Lily may have something that actually helps. If they work out something effective, this could rise from the dead in six months. (That's six months from an effective threapy emerging, not from now.) Interesting.
1 replies